The surrogacy tourism market is estimated at US$ 258.8 million in 2023 and is projected to reach US$ 468.9 million by 2033, at a CAGR of 6.1% from 2023 to 2033. Total sales of surrogacy tourism represent 2-3% of the market.
Gestational surrogacy dominated the tourism market by type and is expected to continue this trend throughout the forecast period, owing to surrogacy professionals' high adoption of gestational techniques and technological advancements.
Major Indicators Creating a Buzz about Surrogacy Tourism
Expensive fertility treatment, unsuccessful infertility treatment, ban of surrogacy practice in many countries, an increase in the number of single parents as well as homosexual couples, and women becoming health conscious are some of the prominent drivers that are boosting the demand for surrogacy tourism all over the globe.
The Challenges and Constraints Confronting the Global Market
The challenges that hinder surrogacy tourism to an extent are less awareness or unclear information about the surrogacy concept and the entire surrogacy tourism exercise.
Moreover, in many regions, surrogacy is an illegal act and banned – countries including Thailand, India, and many others.
The mindset of many couples to have their baby and reliability issues are the other factor that has hampered surrogacy tourism. Other challenges, such as adoption, treatment, and financial, administrative, or practical issues of the service receiver, hinder surrogacy tourism.
Many developing regions such as Asia, the Middle East, and Africa consider single parents and homosexual marriage a taboo; hence due to society's bondage and hesitation, many do not go for practicing surrogacy.
| Attribute | Details |
|---|---|
| Market CAGR (2023 to 2033) | 6.1% |
| Market Valuation (2023) | US$ 258.8 million |
| Market Valuation (2033) | US$ 468.9 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
This process requires great patience, medical and legal knowledge, and a robust support system.
Surrogates have the opportunity to help needy families while also being compensated for their efforts. Ultimately, everyone benefits the intended parents, the surrogate, and any other related person or entity.
Many economic destinations offer surrogacy at a low cost while still providing access to the world's best medical facilities and ART quality. Surrogacy services are available at a meager cost in Kenya, a country that has recently emerged as a favorable hub for fertility tourism.
Surrogacy is a practice in which one woman accepts to abide by pregnancy to grant the newborn baby from that pregnancy to another couple or person, with the mentality that the couple or person would be parent that child.
Technological improvements in aided surrogate technologies, increased awareness regarding infertility treatment, and the development of several fertility clinics drive the growth of the surrogacy tourism market during the forecast period. However, high costs related to the procedure and stringent regulations about surrogacy in several countries restrict the opportunities for surrogacy tourism.
Various factors that lead to infertility include the problem with sperm or egg production, age, genetic factors, and unnecessary exposure to some chemicals and contaminants. Alcohol consumption, steroid use, surgical removal of one of the testicles due to cancer, and diabetes can also result in low sperm count, thereby leading to infertility problems in men, boosting the demand for surrogacy and demand for surrogacy tourism on the whole.
Hormonal disorders, benign uterine growths, abnormal anatomy of the cervix or uterus, blocked fallopian tubes, stress, chemotherapy, kidney, or sickle cell disease can all cause infertility in women, resulting in an increasing trend in demand for surrogacy and demand for surrogacy tourism in general.
The rise in several fertility clinics, along with growth in awareness about fertility treatments such as sperm/egg donation and in-vitro fertilization, escalates the adoption of fertility treatments, thereby propelling the surrogacy tourism market growth.
Moreover, the rise in the prevalence of polycystic ovarian syndrome in women leads to difficulty conceiving a child, resulting in escalated demand for surrogate mothers, thereby expanding surrogacy tourism. However, stringent regulations about commercial methods and the high cost involved in the procedure hamper the global market growth.
Principal Consultant
Technological advancements have played an important role in the market.
The traditional segment of the global market was worth more than US$ 220 million. Traditional surrogacy involves fewer medical procedures and is less expensive than other ART treatments. Traditional surrogacy, on the other hand, carries a higher emotional and legal risk than gestational surrogacy.
Moreover, surrogacy professionals' high adoption of gestational techniques and technological advancements are expected to drive segment growth and surge the surrogacy tourism market. Furthermore, the emotional and legal complexity associated with traditional surrogacy further propels the adoption of gestational surrogacy and the adoption of surrogacy tourism on the whole.
IVF (with ICSI) is considered the safest and best method used for surrogacy.
By technology, the IVF (with ICSI) segment accounted a maximum share in the global market. This segment is expected to exhibit a prominent growth rate, attributed to the fact that it has revolutionized male infertility treatment, as it requires a smaller number of sperm that are penetrated eggs with the help of an injection technique.
Women aged between 26-35 are usually preferred for surrogacy.
The surrogacy process is quite delicate and complex, so the entire process should be carried out with utmost care. It includes the person going through it, i.e., women. As the age grows, the risk factors also increase, which can lead to unwanted consequences like causing harm to both the woman and the fetus inside.
Hence, the age factor is one of the essential elements to be taken care of during the surrogacy process, influencing the surrogacy tourism market's key trends and opportunities.
The presence of sophisticated facilities and equipment for advanced infertility treatments in hospitals to drive segment growth.
The hospital segment of the market was worth more than US$ 1 billion in 2020, owing to an increase in the number of hospitals offering surrogacy treatment and the availability of advanced facilities.
Furthermore, rising healthcare investment and the availability of advanced equipment in hospitals drive the global market. As a result, a positive outcome and the presence of qualified clinical staff for surrogacy treatment in the hospital drive the market.
North America is Expected to Dominate the Global Surrogacy Market
North America is expected to dominate the market due to increased gestational surrogacy, increasing fertility centers, and technological advancements in this region.
For instance, according to the American Society for Reproductive Medicine (ASRM), gestational carrier cycles resulted in more than 75% of infants born. The market share held by the North American market is 26%.
In North American countries, surrogacy is expensive, ranging from around US$ 120,000 to US$ 200,000, especially in the United States.
Europe has the higher share in the global market of approximately 40%.
Surrogacy is recognized under section 30 of the Human Fertilization and Embryology Act 2008; In May 2016, a ruling by the Family Division of the High Court of Justice for England and Wales determined that single people can apply to be recognized as the legal parents of a child following a surrogacy arrangement.
In December 2018, allow applications from individuals subject to conditions, including genetic relation to the child. Singles, as well as homosexuals seeking parenthood, may use it as well, provided that they are United Kingdom residents. The 1985 Surrogacy Arrangements Act prohibits surrogacy-related commercial arrangements.
Apart from the United Kingdom, other major European countries like France, Germany, Spain, and Italy have banned the concept of surrogacy and don't encourage it, hampering the market opportunities.
Due to the low cost of surrogacy treatment and the significant rise in reproductive tourism, the Asia Pacific market captured more than 28% of the revenue share. Furthermore, healthcare facilities for providing fertility treatments are expanding in developing countries.
Thus, low treatment costs, top medical professionals' availability, and favorable surrogacy treatment regulations are influencing regional market growth along with key trends and opportunities.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The competitive landscape of the market has also been examined along with the profiles of the key players like IV Marbella (Spain), Istanbul Fertility and Women's Health Center (Turkey), Intersono IVF Clinic (Ukraine), Embryolab (Greece), GEST (Praga Medica) (Czech Republic), Smart Choice Medical Travel (Hungary), Ava-Peter Clinic (Russia), Nadezhda Fertility Clinic (Bulgaria) and Medicover Fertility (India) among many others.
Recent Developments in the Global Market are:
In 2021, Triangle Capital Corporation announced its acquisition of Bourn Hall Ltd., a British fertility clinic—the purchase to help the company enhance its reach to its customers and offer business expansion opportunities.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Product Type, Mode of Prescription, Sales Channel, Region |
| Key Companies Profiled | IV Marbella (Spain); Istanbul Fertility and Women’s Health Center (Turkey); Intersono IVF Clinic (Ukraine); Embryolab (Greece); GEST (Praga Medica) (Czech Republic); Smart Choice Medical Travel (Hungary); Ava-Peter Clinic (Russia); Nadezhda Fertility Clinic (Bulgaria) and Medicover Fertility (India) |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is expected to secure a valuation of US$ 258.8 million in 2023.
The growth potential of the surrogacy tourism market is 6.1% through 2033.
IV Marbella (Spain), and Istanbul Fertility & Women’s Health Center are the essential market players.
The traditional segment is likely to remain preferred through 2033.
The market is estimated to reach US$ 468.9 million by 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033 5.3.1. Gestational surrogacy 5.3.2. Traditional surrogacy 5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Tour Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Tour Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Tour Type, 2023 to 2033 6.3.1. Domestic 6.3.2. International 6.4. Y-o-Y Growth Trend Analysis By Tour Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Tour Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis by Technology, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by Technology, 2023 to 2033 7.3.1. IVF with ICSI 7.3.2. IVF without ICSI 7.3.3. Intrauterine Insemination 7.4. Y-o-Y Growth Trend Analysis by Technology, 2018 to 2022 7.5. Absolute $ Opportunity Analysis by Technology, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Service Provider 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Service Provider, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service Provider, 2023 to 2033 8.3.1. Hospitals 8.3.2. Fertility Clinics 8.4. Y-o-Y Growth Trend Analysis By Service Provider, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Service Provider, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Age Group 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) Analysis By Age Group, 2018 to 2022 9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Age Group, 2023 to 2033 9.3.1. 26-35 Years 9.3.2. 36-45 Years 9.3.3. 46-55 Years 9.4. Y-o-Y Growth Trend Analysis By Age Group, 2018 to 2022 9.5. Absolute $ Opportunity Analysis By Age Group, 2023 to 2033 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Western Europe 10.3.4. Eastern Europe 10.3.5. South Asia and Pacific 10.3.6. East Asia 10.3.7. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. The USA 11.2.1.2. Canada 11.2.2. By Type 11.2.3. By Tour Type 11.2.4. By Technology 11.2.5. By Service Provider 11.2.6. By Age Group 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Tour Type 11.3.4. By Technology 11.3.5. By Service Provider 11.3.6. By Age Group 11.4. Key Takeaways 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Rest of Latin America 12.2.2. By Type 12.2.3. By Tour Type 12.2.4. By Technology 12.2.5. By Service Provider 12.2.6. By Age Group 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Tour Type 12.3.4. By Technology 12.3.5. By Service Provider 12.3.6. By Age Group 12.4. Key Takeaways 13. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Germany 13.2.1.2. United Kingdom 13.2.1.3. France 13.2.1.4. Spain 13.2.1.5. Italy 13.2.1.6. Rest of Western Europe 13.2.2. By Type 13.2.3. By Tour Type 13.2.4. By Technology 13.2.5. By Service Provider 13.2.6. By Age Group 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Tour Type 13.3.4. By Technology 13.3.5. By Service Provider 13.3.6. By Age Group 13.4. Key Takeaways 14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Poland 14.2.1.2. Russia 14.2.1.3. Czech Republic 14.2.1.4. Romania 14.2.1.5. Rest of Eastern Europe 14.2.2. By Type 14.2.3. By Tour Type 14.2.4. By Technology 14.2.5. By Service Provider 14.2.6. By Age Group 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Tour Type 14.3.4. By Technology 14.3.5. By Service Provider 14.3.6. By Age Group 14.4. Key Takeaways 15. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. India 15.2.1.2. Bangladesh 15.2.1.3. Australia 15.2.1.4. New Zealand 15.2.1.5. Rest of South Asia and Pacific 15.2.2. By Type 15.2.3. By Tour Type 15.2.4. By Technology 15.2.5. By Service Provider 15.2.6. By Age Group 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Type 15.3.3. By Tour Type 15.3.4. By Technology 15.3.5. By Service Provider 15.3.6. By Age Group 15.4. Key Takeaways 16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. China 16.2.1.2. Japan 16.2.1.3. South Korea 16.2.2. By Type 16.2.3. By Tour Type 16.2.4. By Technology 16.2.5. By Service Provider 16.2.6. By Age Group 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Type 16.3.3. By Tour Type 16.3.4. By Technology 16.3.5. By Service Provider 16.3.6. By Age Group 16.4. Key Takeaways 17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 17.2.1. By Country 17.2.1.1. GCC Countries 17.2.1.2. South Africa 17.2.1.3. Israel 17.2.1.4. Rest of MEA 17.2.2. By Type 17.2.3. By Tour Type 17.2.4. By Technology 17.2.5. By Service Provider 17.2.6. By Age Group 17.3. Market Attractiveness Analysis 17.3.1. By Country 17.3.2. By Type 17.3.3. By Tour Type 17.3.4. By Technology 17.3.5. By Service Provider 17.3.6. By Age Group 17.4. Key Takeaways 18. Key Countries Market Analysis 18.1. USA 18.1.1. Pricing Analysis 18.1.2. Market Share Analysis, 2022 18.1.2.1. By Type 18.1.2.2. By Tour Type 18.1.2.3. By Technology 18.1.2.4. By Service Provider 18.1.2.5. By Age Group 18.2. Canada 18.2.1. Pricing Analysis 18.2.2. Market Share Analysis, 2022 18.2.2.1. By Type 18.2.2.2. By Tour Type 18.2.2.3. By Technology 18.2.2.4. By Service Provider 18.2.2.5. By Age Group 18.3. Brazil 18.3.1. Pricing Analysis 18.3.2. Market Share Analysis, 2022 18.3.2.1. By Type 18.3.2.2. By Tour Type 18.3.2.3. By Technology 18.3.2.4. By Service Provider 18.3.2.5. By Age Group 18.4. Mexico 18.4.1. Pricing Analysis 18.4.2. Market Share Analysis, 2022 18.4.2.1. By Type 18.4.2.2. By Tour Type 18.4.2.3. By Technology 18.4.2.4. By Service Provider 18.4.2.5. By Age Group 18.5. Germany 18.5.1. Pricing Analysis 18.5.2. Market Share Analysis, 2022 18.5.2.1. By Type 18.5.2.2. By Tour Type 18.5.2.3. By Technology 18.5.2.4. By Service Provider 18.5.2.5. By Age Group 18.6. United Kingdom 18.6.1. Pricing Analysis 18.6.2. Market Share Analysis, 2022 18.6.2.1. By Type 18.6.2.2. By Tour Type 18.6.2.3. By Technology 18.6.2.4. By Service Provider 18.6.2.5. By Age Group 18.7. France 18.7.1. Pricing Analysis 18.7.2. Market Share Analysis, 2022 18.7.2.1. By Type 18.7.2.2. By Tour Type 18.7.2.3. By Technology 18.7.2.4. By Service Provider 18.7.2.5. By Age Group 18.8. Spain 18.8.1. Pricing Analysis 18.8.2. Market Share Analysis, 2022 18.8.2.1. By Type 18.8.2.2. By Tour Type 18.8.2.3. By Technology 18.8.2.4. By Service Provider 18.8.2.5. By Age Group 18.9. Italy 18.9.1. Pricing Analysis 18.9.2. Market Share Analysis, 2022 18.9.2.1. By Type 18.9.2.2. By Tour Type 18.9.2.3. By Technology 18.9.2.4. By Service Provider 18.9.2.5. By Age Group 18.10. Poland 18.10.1. Pricing Analysis 18.10.2. Market Share Analysis, 2022 18.10.2.1. By Type 18.10.2.2. By Tour Type 18.10.2.3. By Technology 18.10.2.4. By Service Provider 18.10.2.5. By Age Group 18.11. Russia 18.11.1. Pricing Analysis 18.11.2. Market Share Analysis, 2022 18.11.2.1. By Type 18.11.2.2. By Tour Type 18.11.2.3. By Technology 18.11.2.4. By Service Provider 18.11.2.5. By Age Group 18.12. Czech Republic 18.12.1. Pricing Analysis 18.12.2. Market Share Analysis, 2022 18.12.2.1. By Type 18.12.2.2. By Tour Type 18.12.2.3. By Technology 18.12.2.4. By Service Provider 18.12.2.5. By Age Group 18.13. Romania 18.13.1. Pricing Analysis 18.13.2. Market Share Analysis, 2022 18.13.2.1. By Type 18.13.2.2. By Tour Type 18.13.2.3. By Technology 18.13.2.4. By Service Provider 18.13.2.5. By Age Group 18.14. India 18.14.1. Pricing Analysis 18.14.2. Market Share Analysis, 2022 18.14.2.1. By Type 18.14.2.2. By Tour Type 18.14.2.3. By Technology 18.14.2.4. By Service Provider 18.14.2.5. By Age Group 18.15. Bangladesh 18.15.1. Pricing Analysis 18.15.2. Market Share Analysis, 2022 18.15.2.1. By Type 18.15.2.2. By Tour Type 18.15.2.3. By Technology 18.15.2.4. By Service Provider 18.15.2.5. By Age Group 18.16. Australia 18.16.1. Pricing Analysis 18.16.2. Market Share Analysis, 2022 18.16.2.1. By Type 18.16.2.2. By Tour Type 18.16.2.3. By Technology 18.16.2.4. By Service Provider 18.16.2.5. By Age Group 18.17. New Zealand 18.17.1. Pricing Analysis 18.17.2. Market Share Analysis, 2022 18.17.2.1. By Type 18.17.2.2. By Tour Type 18.17.2.3. By Technology 18.17.2.4. By Service Provider 18.17.2.5. By Age Group 18.18. China 18.18.1. Pricing Analysis 18.18.2. Market Share Analysis, 2022 18.18.2.1. By Type 18.18.2.2. By Tour Type 18.18.2.3. By Technology 18.18.2.4. By Service Provider 18.18.2.5. By Age Group 18.19. Japan 18.19.1. Pricing Analysis 18.19.2. Market Share Analysis, 2022 18.19.2.1. By Type 18.19.2.2. By Tour Type 18.19.2.3. By Technology 18.19.2.4. By Service Provider 18.19.2.5. By Age Group 18.20. South Korea 18.20.1. Pricing Analysis 18.20.2. Market Share Analysis, 2022 18.20.2.1. By Type 18.20.2.2. By Tour Type 18.20.2.3. By Technology 18.20.2.4. By Service Provider 18.20.2.5. By Age Group 18.21. GCC Countries 18.21.1. Pricing Analysis 18.21.2. Market Share Analysis, 2022 18.21.2.1. By Type 18.21.2.2. By Tour Type 18.21.2.3. By Technology 18.21.2.4. By Service Provider 18.21.2.5. By Age Group 18.22. South Africa 18.22.1. Pricing Analysis 18.22.2. Market Share Analysis, 2022 18.22.2.1. By Type 18.22.2.2. By Tour Type 18.22.2.3. By Technology 18.22.2.4. By Service Provider 18.22.2.5. By Age Group 18.23. Israel 18.23.1. Pricing Analysis 18.23.2. Market Share Analysis, 2022 18.23.2.1. By Type 18.23.2.2. By Tour Type 18.23.2.3. By Technology 18.23.2.4. By Service Provider 18.23.2.5. By Age Group 19. Market Structure Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Market Share Analysis of Top Players 19.3.1. By Regional 19.3.2. By Type 19.3.3. By Tour Type 19.3.4. By Technology 19.3.5. By Service Provider 19.3.6. By Age Group 20. Competition Analysis 20.1. Competition Deep Dive 20.1.1. Istanbul Fertility and Women’s Health Center 20.1.1.1. Overview 20.1.1.2. Product Portfolio 20.1.1.3. Profitability by Market Segments 20.1.1.4. Sales Footprint 20.1.1.5. Strategy Overview 20.1.1.5.1. Marketing Strategy 20.1.2. Intersono IVF Clinic 20.1.2.1. Overview 20.1.2.2. Product Portfolio 20.1.2.3. Profitability by Market Segments 20.1.2.4. Sales Footprint 20.1.2.5. Strategy Overview 20.1.2.5.1. Marketing Strategy 20.1.3. Embryolab 20.1.3.1. Overview 20.1.3.2. Product Portfolio 20.1.3.3. Profitability by Market Segments 20.1.3.4. Sales Footprint 20.1.3.5. Strategy Overview 20.1.3.5.1. Marketing Strategy 20.1.4. GEST (Praga Medica) 20.1.4.1. Overview 20.1.4.2. Product Portfolio 20.1.4.3. Profitability by Market Segments 20.1.4.4. Sales Footprint 20.1.4.5. Strategy Overview 20.1.4.5.1. Marketing Strategy 20.1.5. IV Marbella 20.1.5.1. Overview 20.1.5.2. Product Portfolio 20.1.5.3. Profitability by Market Segments 20.1.5.4. Sales Footprint 20.1.5.5. Strategy Overview 20.1.5.5.1. Marketing Strategy 20.1.6. Smart Choice Medical Travel 20.1.6.1. Overview 20.1.6.2. Product Portfolio 20.1.6.3. Profitability by Market Segments 20.1.6.4. Sales Footprint 20.1.6.5. Strategy Overview 20.1.6.5.1. Marketing Strategy 20.1.7. Ava-Peter Clinic 20.1.7.1. Overview 20.1.7.2. Product Portfolio 20.1.7.3. Profitability by Market Segments 20.1.7.4. Sales Footprint 20.1.7.5. Strategy Overview 20.1.7.5.1. Marketing Strategy 20.1.8. Nadezhda Fertility Clinic 20.1.8.1. Overview 20.1.8.2. Product Portfolio 20.1.8.3. Profitability by Market Segments 20.1.8.4. Sales Footprint 20.1.8.5. Strategy Overview 20.1.8.5.1. Marketing Strategy 20.1.9. Medicover Fertility 20.1.9.1. Overview 20.1.9.2. Product Portfolio 20.1.9.3. Profitability by Market Segments 20.1.9.4. Sales Footprint 20.1.9.5. Strategy Overview 20.1.9.5.1. Marketing Strategy 20.1.10. Circle Surrogacy 20.1.10.1. Overview 20.1.10.2. Product Portfolio 20.1.10.3. Profitability by Market Segments 20.1.10.4. Sales Footprint 20.1.10.5. Strategy Overview 20.1.10.5.1. Marketing Strategy 20.1.11. Clinic Scanfert 20.1.11.1. Overview 20.1.11.2. Product Portfolio 20.1.11.3. Profitability by Market Segments 20.1.11.4. Sales Footprint 20.1.11.5. Strategy Overview 20.1.11.5.1. Marketing Strategy 20.1.12. IVIRMA 20.1.12.1. Overview 20.1.12.2. Product Portfolio 20.1.12.3. Profitability by Market Segments 20.1.12.4. Sales Footprint 20.1.12.5. Strategy Overview 20.1.12.5.1. Marketing Strategy 20.1.13. NOVA 20.1.13.1. Overview 20.1.13.2. Product Portfolio 20.1.13.3. Profitability by Market Segments 20.1.13.4. Sales Footprint 20.1.13.5. Strategy Overview 20.1.13.5.1. Marketing Strategy 20.1.14. Bnagkok IVF Centre 20.1.14.1. Overview 20.1.14.2. Product Portfolio 20.1.14.3. Profitability by Market Segments 20.1.14.4. Sales Footprint 20.1.14.5. Strategy Overview 20.1.14.5.1. Marketing Strategy 21. Assumptions & Acronyms Used 22. Research Methodology
Explore Travel and Tourism Insights
View Reports
Surrogacy Tourism Market
